861
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy and toxicity of conventionally fractionated pelvic radiation with a hypofractionated simultaneous versus conventionally fractionated sequential boost for patients with high-risk prostate cancer

, , , &
Pages 1181-1188 | Received 28 Aug 2012, Accepted 05 Nov 2012, Published online: 02 Apr 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Andreas G. Andersen, Oscar Casares-Magaz, Ludvig P. Muren, Jakob Toftegaard, Lise Bentzen, Sara Thörnqvist & Jørgen B. B. Petersen. (2015) A method for evaluation of proton plan robustness towards inter-fractional motion applied to pelvic lymph node irradiation. Acta Oncologica 54:9, pages 1643-1650.
Read now
Morten Høyer, Ludvig P. Muren & Bengt Glimelius. (2015) The evolution of radiotherapy techniques in the management of prostate cancer. Acta Oncologica 54:6, pages 821-824.
Read now
Jimmi Søndergaard, Mats Holmberg, Annette Ross Jakobsen, Mads Agerbæk, Ludvig Paul Muren & Morten Høyer. (2014) A comparison of morbidity following conformal versus intensity-modulated radiotherapy for urinary bladder cancer. Acta Oncologica 53:10, pages 1321-1328.
Read now

Articles from other publishers (9)

Ingrid Masson, Laurène Larriviere, Marc-André Mahé, David Azria, Pascal Pommier, Nathalie Mesgouez-Nebout, Philippe Giraud, Didier Peiffert, Bruno Chauvet, Philippe Dudouet, Naji Salem, Georges Noël, Jonathan Khalifa, Igor Latorzeff, Catherine Guérin-Charbonnel & Stéphane Supiot. (2024) Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer. Clinical and Translational Radiation Oncology 44, pages 100702.
Crossref
F. Sinzabakira, V. Brand, W.D. Heemsbergen & L. Incrocci. (2023) Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis. Clinical and Translational Radiation Oncology 40, pages 100612.
Crossref
Richard Choo, David W. Hillman, Cecilia Mitchell, Thomas Daniels, Carlos Vargas, Jean Claude Rwigema, Kimberly Corbin, Sameer Keole, Sujay Vora, Kenneth Merrell, Bradley Stish, Thomas Pisansky, Brian J. Davis, Adam Amundson & William Wong. (2023) Late Toxicity of Moderately Hypofractionated Intensity-Modulated Proton Therapy Treating the Prostate and Pelvic Lymph Nodes for High-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics 115:5, pages 1085-1094.
Crossref
Gustavo A. Viani, Andre G. Gouveia, Fabio Y. Moraes & Fabio L. Cury. (2022) Meta-analysis of Elective Pelvic Nodal Irradiation Using Moderate Hypofractionation for High-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics 113:5, pages 1044-1053.
Crossref
Felix Sinzabakira, Wilma D. Heemsbergen, Floris J. Pos & Luca Incrocci. (2022) Patient-Reported Outcomes in the Acute Phase of the Randomized Hypofractionated Irradiation for Prostate Cancer (HYPRO) Trial. International Journal of Radiation Oncology*Biology*Physics 112:4, pages 870-879.
Crossref
P. Cheung, T. Niazi, S. Faria & A. Loblaw. (2020) Elective Pelvic Nodal Irradiation With a Simultaneous Hypofractionated Integrated Prostate Boost for Localised Prostate Cancer: Ready for Prime Time?. Clinical Oncology 32:3, pages 181-188.
Crossref
Andrew M. McDonald, Samuel J. Galgano, Jonathan E. McConathy, Eddy S. Yang, Michael C. Dobelbower, Rojymon Jacob, Soroush Rais-Bahrami, Jeffrey W. Nix, Richard A. Popple & John B. Fiveash. (2019) Feasibility of Dose Escalating [18F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate Cancer. Advances in Radiation Oncology 4:4, pages 649-658.
Crossref
Andrew M. McDonald, Michael C. Dobelbower, Eddy S. Yang, Grant M. Clark, Rojymon Jacob, Robert Y. Kim, Rex A. Cardan, Richard Popple, Jeffrey W. Nix, Soroush Rais-Bahrami & John B. Fiveash. (2019) Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective Trial. Advances in Radiation Oncology 4:1, pages 90-95.
Crossref
S. Supiot, G. Créhange, I. Latorzeff, P. Pommier, A. Paumier, E. Rio, G. Delaroche, S. Guérif, C. Catton, J. Martin & A. Lisbona. (2013) Hypofractionnement à visée curative dans le cancer de la prostate. Cancer/Radiothérapie 17:5-6, pages 349-354.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.